The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.
Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis
Open accessAbstract
The diagnosis of amyotrophic lateral sclerosis can be challenging due to its heterogeneity in clinical presentation and overlap with other neurological disorders. Diagnosis early in the disease course can improve outcomes as timely interventions can slow disease progression. An evolving awareness of disease genotypes and phenotypes and new diagnostic criteria, such as the recent Gold Coast criteria, could expedite diagnosis. Improved prognosis, such as that achieved with the survival model from the European Network for the Cure of ALS, could inform the patient and their family about disease course and improve end-of-life planning. Novel staging and scoring systems can help monitor disease progression and might potentially serve as clinical trial outcomes. Lastly, new tools, such as fluid biomarkers, imaging modalities, and neuromuscular electrophysiological measurements, might increase diagnostic and prognostic accuracy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“monogenic ALS mutations may still exhibit incomplete penetrance or delayed onset [8]”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“as exposure to certain environmental factors might modify the risk the mutations confer [8].”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationCedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., Mclaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., HortobáGyi, T., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1267768 · Cited by 909
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862
Self-citationThe phenotypic variability of amyotrophic lateral sclerosis
Swinnen, B., & Robberecht, W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.184 · Cited by 647
Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study
Chiò, A., Calvo, A., Moglia, C., Mazzini, L., Mora, G., & PARALS study group (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.235952 · Cited by 626
Self-citationA proposal for new diagnostic criteria for ALS
Shefner, J. M., Al‐Chalabi, A., Baker, M. R., Cui, L., de Carvalho, M. A., Eisen, A., Großkreutz, J., Hardiman, O. M., Henderson, R. D., Matamala, J. M., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.04.005 · Cited by 622
Self-citationNovel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Chia, R., Chiò, A., & Traynor, B. J. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30401-5 · Cited by 592
Self-citationWesteneng, H., Debray, T. P. A., Visser, A. E., van Eijk, R. P. A., Rooney, J. P. K., Calvo, A., Opie-Martin, S., McDermott, C. J., Thompson, A. G., Pinto, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30089-9 · Cited by 544
Self-citationProjected increase in amyotrophic lateral sclerosis from 2015 to 2040
Arthur, K. C., Calvo, A., Price, T. R., Geiger, J. T., Chiò, A., & Traynor, B. J. (2016) · Nature Communications · doi:10.1038/ncomms12408 · Cited by 515
Self-citationA proposed staging system for amyotrophic lateral sclerosis
Roche, J. C., Rojas‐García, R., Scott, K. M., Scotton, W. J., Ellis, C. E., Burman, R., Wijesekera, L. C., Turner, M. R., Leigh, P. N., Shaw, C. E., et al. (2012) · Brain · doi:10.1093/brain/awr351 · Cited by 469
Self-citationEmerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
Goutman, S. A., Hardiman, O. M., Al‐Chalabi, A., Chiò, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00414-2 · Cited by 432
Self-citationVariation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
Marin, B., Boumédiène, F., Logroscino, G., Couratier, P., Babron, M., Leutenegger, A., Copetti, M., Preux, P., & Beghi, E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw061 · Cited by 368
Neurofilaments: neurobiological foundations for biomarker applications
Gafson, A., Barthélemy, N. R., Bomont, P., Carare, R. O., Durham, H. D., Julien, J., Kühle, J., Leppert, D., Nixon, R. A., Weller, R. O., et al. (2020) · Brain · doi:10.1093/brain/awaa098 · Cited by 339
Xu, L., Liu, T., Liu, L., Yao, X., Chen, L., Fan, D., Zhan, S., & Wang, S. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09652-y · Cited by 330
Benatar, M. G., Wuu, J., Andersen, P. M., Lombardi, V., & Malaspina, A. (2018) · Annals of Neurology · doi:10.1002/ana.25276 · Cited by 309
Improving clinical trial outcomes in amyotrophic lateral sclerosis
Kiernan, M. C., Vucic, S., Talbot, K., McDermott, C. J., Hardiman, O. M., Shefner, J. M., Al‐Chalabi, A., Huynh, W., Cudkowicz, M., Talman, P. S., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-00434-z · Cited by 306
Self-citationCognitive changes predict functional decline in ALS
Elamin, M., Bede, P., Byrne, S., Jordan, N., Gallagher, L. B., Wynne, B., O’Brien, C., Phukan, J., Lynch, C. M., Pender, N. P., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f18ac · Cited by 272
Self-citationALS-specific cognitive and behavior changes associated with advancing disease stage in ALS
Crockford, C., Newton, J. L., Lonergan, K., Chiwera, T., Booth, T., Chandran, S., Colville, S., Heverin, M., Mays, I., Pal, S., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006317 · Cited by 264
Self-citationAwaji Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis: A Systematic Review
Costa, J., Swash, M., & de Carvalho, M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.254 · Cited by 249
Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis
Ryan, M., Heverin, M., McLaughlin, R. L., & Hardiman, O. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2044 · Cited by 244
Self-citationNeurofilament markers for ALS correlate with extent of upper and lower motor neuron disease
Poesen, K., Schaepdryver, M. D., Stubendorff, B., Gille, B., Muckova, P., Wendler, S., Prell, T., Ringer, T. M., Rhode, H., Stevens, O., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004029 · Cited by 237
Cortical influences drive amyotrophic lateral sclerosis
Eisen, A., Braak, H., Tredici, K. D., Lemon, R., Ludolph, A. C., & Kiernan, M. C. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315573 · Cited by 227
Self-citationMenon, P., Geevasinga, N., Yiannikas, C., Howells, J., Kiernan, M. C., & Vucic, S. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00014-9 · Cited by 217
Self-citationThe sex ratio in amyotrophic lateral sclerosis: A population based study
Manjaly, Z.-R., Scott, K. M., Abhinav, K., Wijesekera, L. C., Ganesalingam, J., Goldstein, L. H., Janssen, A. L., Dougherty, A., Willey, E., Stanton, B. R., et al. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482961003610853 · Cited by 210
Self-citationDevelopment and evaluation of a clinical staging system for amyotrophic lateral sclerosis
Chiò, A., Hammond, E. R., Mora, G., Bonito, V., & Filippini, G. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306589 · Cited by 206
Self-citationValidation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Benatar, M. G., Zhang, L., Wang, L. H.-C., Granit, V., Statland, J., Barohn, R. J., Swenson, A., Ravits, J., Jackson, C. E., Burns, T. M., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009559 · Cited by 205
Rabinovici, G. D., Stephens, M. L., & Possin, K. L. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000466658.05156.54 · Cited by 205
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies
Hensman Moss, D. J., Poulter, M., Beck, J., Hehir, J., Polke, J. M., Campbell, T., Adamson, G., Mudanohwo, E., McColgan, P., Haworth, A., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000061 · Cited by 203
Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis
Richards, D., Morren, J. A., & Pioro, E. P. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117054 · Cited by 185
ALS phenotype is influenced by age, sex, and genetics
Chiò, A., Moglia, C., Canosa, A., Manera, U., D’Ovidio, F., Vasta, R., Grassano, M., Brunetti, M., Barberis, M., Corrado, L., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000008869 · Cited by 173
Self-citationMachine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions
Grollemund, V., Pradat, P., Querin, G., Delbot, F., Chat, G. L., Pradat‐Peyre, J., & Bede, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00135 · Cited by 165
Prevalence of Amyotrophic Lateral Sclerosis — United States, 2015
Mehta, P., Kaye, W., Raymond, J. S., Punjani, R., Larson, T. C., III, Cohen, J., Muravov, O. I., & Horton, D. K. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6746a1 · Cited by 160
Age-related penetrance of the C9orf72 repeat expansion
Murphy, N. A., Arthur, K. C., Tienari, P. J., Houlden, H., Chiò, A., & Traynor, B. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-02364-1 · Cited by 152
Self-citationRevised Airlie House consensus guidelines for design and implementation of ALS clinical trials
van den Berg, L. H., Sorenson, E. J., Gronseth, G., Macklin, E. A., Andrews, J. A., Baloh, R. H., Benatar, M. G., Berry, J. D., Chiò, A., Corcia, P., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007242 · Cited by 149
Self-citationGenetic correlation between amyotrophic lateral sclerosis and schizophrenia
McLaughlin, R. L., Schijven, D., van Rheenen, W., van Eijk, K. R., O’Brien, M., Kahn, R. S., Ophoff, R. A., Goris, A., Bradley, D. G., Al‐Chalabi, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14774 · Cited by 148
Self-citationDiagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis
Hannaford, A. P., Pavey, N., van den Bos, M. A. J., Geevasinga, N., Menon, P., Shefner, J. M., Kiernan, M. C., & Vucic, S. (2021) · Annals of Neurology · doi:10.1002/ana.26045 · Cited by 145
Self-citationWainger, B. J., Macklin, E. A., Vucic, S., McIlduff, C. E., Paganoni, S., Maragakis, N. J., Bedlack, R., Goyal, N., Rutkove, S. B., Lange, D. J., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4300 · Cited by 142
Self-citationRooney, J. P. K., Burke, T., Vajda, A., Heverin, M., & Hardiman, O. M. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314661 · Cited by 137
Self-citationThe two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
Menke, R., Proudfoot, M., Talbot, K., & Turner, M. R. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.12.025 · Cited by 124
Fasciculation in amyotrophic lateral sclerosis: origin and pathophysiological relevance
de Carvalho, M. A., Kiernan, M. C., & Swash, M. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315574 · Cited by 113
Self-citationLongitudinal biomarkers in amyotrophic lateral sclerosis
Huang, F., Zhu, Y., Hsiao‐Nakamoto, J., Tang, X., Dugas, J. C., Moscovitch‐Lopatin, M., Glass, J. D., Brown, R. H., Ladha, S. S., Lacomis, D., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51078 · Cited by 111
Saba, L., Viscomi, M. T., Caioli, S., Pignataro, A., Bisicchia, E., Pieri, M., Molinari, M., Ammassari‐Teule, M., & Zona, C. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhu317 · Cited by 110
Bede, P., & Hardiman, O. M. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1407795 · Cited by 109
Self-citationSchuster, C., Hardiman, O. M., & Bede, P. (2017) · BMC Neurology · doi:10.1186/s12883-017-0854-x · Cited by 108
Self-citationNasseroleslami, B., Dukic, S., Broderick, M. P., Mohr, K. S., Schuster, C., Gavin, B., McLaughlin, R. L., Heverin, M., Vajda, A., Iyer, P. M., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx301 · Cited by 107
Self-citationComprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes
Yang, C., Li, X., Wu, Y., Shen, Q., Zeng, Y., Xiong, Q., Wei, M., Chen, C., Liu, J., Huo, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03247-3 · Cited by 106
Halbgebauer, S., Steinacker, P., Verde, F., Weishaupt, J. H., Oeckl, P., Arnim, C. A. F. V., Dorst, J., Feneberg, E., Mayer, B., Rosenbohm, A., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327129 · Cited by 105
How common are ALS plateaus and reversals?
Bedlack, R., Vaughan, T. E., Wicks, P. J., Heywood, J., Sinani, E., Selsov, R., Macklin, E. A., Schoenfeld, D., Cudkowicz, M., & Sherman, A. (2015) · Neurology · doi:10.1212/wnl.0000000000002251 · Cited by 103
Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts—Novel Techniques
Mendili, M. M. E., Querin, G., Bede, P., & Pradat, P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00350 · Cited by 102
Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cernasov, P., Reynolds, B., Pijanowski, O., Chonde, D. B., Izquierdo‐Garcia, D., Mainero, C., Catana, C., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25251 · Cited by 99
Psychiatric disorders in C9orf72 kindreds
Devenney, E. M., Ahmed, R. M., Halliday, G. M., Piguet, O., Kiernan, M. C., & Hodges, J. R. (2018) · Neurology · doi:10.1212/wnl.0000000000006344 · Cited by 99
Self-citationQuantitative Susceptibility MRI to Detect Brain Iron in Amyotrophic Lateral Sclerosis
Acosta‐Cabronero, J., Machts, J., Schreiber, S., Abdulla, S., Kollewe, K., Petri, S., Spotorno, N., Kaufmann, J., Heinze, H., Dengler, R., et al. (2018) · Radiology · doi:10.1148/radiol.2018180112 · Cited by 95
Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study
Querin, G., Bede, P., Mendili, M. M. E., Li, M., Pélégrini‐Issac, M., Rinaldi, D., Catala, M., Saracino, D., Salachas, F., Camuzat, A., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25520 · Cited by 95
Patterned functional network disruption in amyotrophic lateral sclerosis
Dukic, S., McMackin, R., Buxó, T., Fasano, A., Chipika, R. H., Pinto‐Grau, M., Costello, E., Schuster, C., Hammond, M., Heverin, M., et al. (2019) · Human Brain Mapping · doi:10.1002/hbm.24740 · Cited by 95
Self-citationDewan, R., Chia, R., Ding, J., Hickman, R. A., Stein, T. D., Abramzon, Y. A., Ahmed, S., Sabir, M. S., Portley, M. K., Tucci, A., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.11.005 · Cited by 95
Self-citationCortical hyperexcitability evolves with disease progression in ALS
Menon, P., Higashihara, M., van den Bos, M. A. J., Geevasinga, N., Kiernan, M. C., & Vucic, S. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51039 · Cited by 89
Self-citationTalman, P. S., Duong, T. V., Vucic, S., Mathers, S., Venkatesh, S., Henderson, R. D., Rowe, D. B., Schultz, D. W., Edis, R. H., Needham, M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012054 · Cited by 87
Self-citationIdentifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI)
Elamin, M., Pinto‐Grau, M., Burke, T., Bede, P., Rooney, J. P. K., O’Sullivan, M., Lonergan, K., Kirby, E., Quinlan, E., Breen, N., et al. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1248976 · Cited by 86
Self-citationSchuster, C., Hardiman, O. M., & Bede, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167331 · Cited by 83
Self-citationComparison of the King’s and MiToS staging systems for ALS
Fang, T., Khleifat, A. A., Stahl, D. R., Torre, C. L. L., Murphy, C., LicalS, U.-M., Young, C. A., Shaw, P. J., Leigh, P. N., & Al‐Chalabi, A. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1265565 · Cited by 83
Self-citationBurke, T., Pinto‐Grau, M., Lonergan, K., Bede, P., O’Sullivan, M., Heverin, M., Vajda, A., McLaughlin, R. L., Pender, N. P., & Hardiman, O. M. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.407 · Cited by 82
Self-citationFournier, C. N., Bedlack, R., Quinn, C. C., Russell, J., Beckwith, D., Kaminski, K. H., Tyor, W. R., Hertzberg, V., James, V., Polak, M. A., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4490 · Cited by 82
Defining pre-symptomatic amyotrophic lateral sclerosis
Benatar, M. G., Turner, M. R., & Wuu, J. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2019.1587634 · Cited by 80
Diagnosis and Clinical Management of Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Goutman, S. A. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000535 · Cited by 79
Self-citationImproving symptom management for people with amyotrophic lateral sclerosis
Nicholson, K. A., Murphy, A., McDonnell, E., Shapiro, J. D., Simpson, E. P., Glass, J. D., Mitsumoto, H., Forshew, D. A., Miller, R. G., & Atassi, N. (2017) · Muscle & Nerve · doi:10.1002/mus.25712 · Cited by 79
Connectome‐Based Propagation Model in Amyotrophic Lateral Sclerosis
Meier, J. M., van der Burgh, H. K., Nitert, A. D., Bede, P., de Lange, S. C., Hardiman, O. M., van den Berg, L. H., & van den Heuvel, M. P. (2020) · Annals of Neurology · doi:10.1002/ana.25706 · Cited by 77
Self-citationSorrentino, P., Rucco, R., Jacini, F., Trojsi, F., Lardone, A., Baselice, F., Femiano, C., Santangelo, G., Granata, C., Vettoliere, A., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.08.001 · Cited by 76
Multimodal structural MRI in the diagnosis of motor neuron diseases
Ferraro, P. M., Agosta, F., Riva, N., Copetti, M., Spinelli, E. G., Falzone, Y., Sorarú, G., Comı, G., Chiò, A., & Filippi, M. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.08.002 · Cited by 74
Self-citationGold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis
Pugdahl, K., Camdessanché, J., Çengiz, B., de Carvalho, M. A., Liguori, R., Rossatto, C., Santos, M. O., Vacchiano, V., & Johnsen, B. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.08.014 · Cited by 73
van Eijk, R. P. A., de Jongh, A. D., Nikolakopoulos, S., McDermott, C. J., Eijkemans, M. J. C., Roes, K. C. B., & van den Berg, L. H. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1879865 · Cited by 72
Choi, S., Hong, Y., Kim, S., Shin, J.-Y., Suh, Y. J., & Sung, J. (2020) · Scientific Reports · doi:10.1038/s41598-019-57366-y · Cited by 69
A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS
Kalra, S., Müller, H., Ishaque, A. H., Zinman, L. H., Korngut, L. W., Genge, A. L., Beaulieu, C., Frayne, R., Graham, S. J., & Kassubek, J. (2020) · Neurology · doi:10.1212/wnl.0000000000010235 · Cited by 69
Structural and functional brain connectome in motor neuron diseases
Basaia, S., Agosta, F., Cividini, C., Trojsi, F., Riva, N., Spinelli, E. G., Moglia, C., Femiano, C., Castelnovo, V., Canu, E., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010731 · Cited by 68
Self-citationNeurophysiological biomarkers in amyotrophic lateral sclerosis
Vucic, S., & Rutkove, S. B. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000593 · Cited by 68
Galvin, M., Ryan, P., Maguire, S., Heverin, M., Madden, C., Vajda, A., Normand, C. E. M., & Hardiman, O. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179796 · Cited by 68
Self-citationQuerin, G., Mendili, M. M. E., Lenglet, T., Delphine, S., Marchand‐Pauvert, V., Benali, H., & Pradat, P. (2017) · European Journal of Neurology · doi:10.1111/ene.13329 · Cited by 66
Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollment
Vucic, S., Ferguson, T. A., Cummings, C., Hotchkin, M. T., Genge, A. L., Glanzman, R., Roet, K. C. D., Cudkowicz, M., & Kiernan, M. C. (2021) · Muscle & Nerve · doi:10.1002/mus.27392 · Cited by 66
Self-citationGeevasinga, N., Menon, P., Sue, C. M., Kumar, K. R., Ng, K., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2015) · European Journal of Neurology · doi:10.1111/ene.12669 · Cited by 64
Self-citationCortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS
Vucic, S., Pavey, N., Haidar, M., Turner, B. J., & Kiernan, M. C. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136039 · Cited by 52
Self-citationEmerging understanding of the genotype–phenotype relationship in amyotrophic lateral sclerosis
Goutman, S. A., Chen, K. S., Paez-Colasante, X., & Feldman, E. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00039-9 · Cited by 50
Self-citationThe prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients
Pirola, A., Mattia, E. D., Lizio, A., Sannicolò, G., Carraro, E., Rao, F., Sansone, V., & Lunetta, C. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.105456 · Cited by 45
Shen, D., Yang, X., Wang, Y., He, D., Sun, X., Cai, Z., Li, J., Liu, M., & Cui, L. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00253-2 · Cited by 44
Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19
Al‐Chalabi, A., Chiò, A., Merrill, C., Oster, G., Bornheimer, R., Agnese, W., & Apple, S. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323271 · Cited by 43
Self-citationWelton, T., Maller, J. J., Lebel, R. M., Tan, E. T., Rowe, D. B., & Grieve, S. M. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101953 · Cited by 43
Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis
Fabes, J., Matthews, L., Filippini, N., Talbot, K., Jenkinson, M., & Turner, M. R. (2017) · Academic Radiology · doi:10.1016/j.acra.2017.04.008 · Cited by 41
The motor band sign in ALS: presentations and frequencies in a consecutive series of ALS patients
Röeben, B., Wilke, C., Bender, B., Ziemann, U., & Synofzik, M. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116440 · Cited by 41
Imaging in amyotrophic lateral sclerosis: MRI and PET
Kassubek, J., & Pagani, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000728 · Cited by 40
The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis
Caga, J., Hsieh, S., Highton‐Williamson, E., Zoing, M. C., Ramsey, E., Devenney, E. M., Ahmed, R. M., Hogden, A., & Kiernan, M. C. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1497659 · Cited by 37
Self-citationNeurochemical biomarkers in amyotrophic lateral sclerosis
Verde, F., Silani, V., & Otto, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000744 · Cited by 36
Expanding the Spectrum of Movement Disorders Associated With C9orf72 Hexanucleotide Expansions
Estevez‐Fraga, C., Magrinelli, F., Moss, D. J. H., Mulroy, E., Lazzaro, G. D., Latorre, A., Mackenzie, M., Houlden, H., Tabrizi, S. J., & Bhatia, K. P. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000575 · Cited by 36
Tang, M., Gao, C., Goutman, S. A., Kalinin, A. A., Mukherjee, B., Guan, Y., & Dinov, I. D. (2018) · Neuroinformatics · doi:10.1007/s12021-018-9406-9 · Cited by 35
Self-citationDharmadasa, T., Matamala, J. M., Howells, J., Vucic, S., & Kiernan, M. C. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.057 · Cited by 35
Self-citationOccasional essay: upper motor neuron syndrome in amyotrophic lateral sclerosis
Swash, M., Burke, D., Turner, M. R., Grosskreutz, J., Leigh, P. N., deCarvalho, M., & Kiernan, M. C. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321938 · Cited by 35
Self-citationFunctional Biomarkers for Amyotrophic Lateral Sclerosis
Huynh, W., Dharmadasa, T., Vucic, S., & Kiernan, M. C. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2018.01141 · Cited by 32
Self-citationRegional motor cortex dysfunction in amyotrophic lateral sclerosis
Menon, P., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50819 · Cited by 31
Self-citationD’hulst, L., Weehaeghe, D. V., Chiò, A., Calvo, A., Moglia, C., Canosa, A., Cistaro, A., Willekens, S. M. A., Vocht, J. D., Damme, P. V., et al. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1476548 · Cited by 30
Self-citationCombined brain and spinal FDG PET allows differentiation between ALS and ALS mimics
Weehaeghe, D. V., Devrome, M., Schramm, G., Vocht, J. D., Deckers, W., Baete, K., Damme, P. V., Koole, M. J. B., & Laere, K. V. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04786-y · Cited by 30
Survival prediction models in motor neuron disease
Agosta, F., Spinelli, E. G., Riva, N., Fontana, A., Basaia, S., Canu, E., Castelnovo, V., Falzone, Y., Carrera, P., Comı, G., et al. (2019) · European Journal of Neurology · doi:10.1111/ene.13957 · Cited by 27
Motor cortical excitability predicts cognitive phenotypes in amyotrophic lateral sclerosis
Agarwal, S., Highton‐Williamson, E., Caga, J., Howells, J., Dharmadasa, T., Matamala, J. M., Ma, Y., Shibuya, K., Hodges, J. R., Ahmed, R. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81612-x · Cited by 24
Self-citationCortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis
Dharmadasa, T., Howells, J., Matamala, J. M., Simon, N. G., Burke, D. J., Vucic, S., & Kiernan, M. C. (2020) · European Journal of Neurology · doi:10.1111/ene.14515 · Cited by 20
Self-citationAmyotrophic lateral sclerosis or not: Keys for the diagnosis
Lenglet, T., & Camdessanché, J. (2017) · Revue Neurologique · doi:10.1016/j.neurol.2017.04.003 · Cited by 19
Patterns of Language Impairment in Early Amyotrophic Lateral Sclerosis
Pinto‐Grau, M., Donohoe, B., O’Connor, S. S., Murphy, L., Costello, E., Heverin, M., Vajda, A., Hardiman, O. M., & Pender, N. P. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001006 · Cited by 17
Self-citationLuna, J., Couratier, P., Lahmadi, S., Lautrette, G., Fontana, A., Tortelli, R., Logroscino, G., Preux, P., Copetti, M., & Marin, B. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1903506 · Cited by 12
Moglia, C., Calvo, A., Brunetti, M., Chiò, A., & Grassano, M. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04751-5 · Cited by 9
Self-citationThe life expectancy of Stephen Hawking, according to the ENCALS model
Westeneng, H., Al‐Chalabi, A., Hardiman, O. M., Debray, T. P. A., & van den Berg, L. H. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30241-2 · Cited by 8
Self-citation
Research works printed but not linked: 1
- Pinto-Grau, 2020, Patterns of language impairment in early ALS, Neurol Clin Pract, 11, e634
Cited by
Sorted by citations
Feldman, E. L., Goutman, S. A., Petri, S., Mazzini, L., Savelieff, M. G., Shaw, P. J., & Sobue, G. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01272-7 · Cited by 1,267
Self-citationNeurofilaments as biomarkers in neurological disorders — towards clinical application
Khalil, M., Teunissen, C. E., Lehmann, S., Otto, M., Piehl, F., Ziemssen, T., Bittner, S., Sormani, M. P., Gattringer, T., Abu‐Rumeileh, S., et al. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00955-x · Cited by 503
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
Goutman, S. A., Hardiman, O. M., Al‐Chalabi, A., Chiò, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00414-2 · Cited by 432
Self-citationInnate immune activation in neurodegenerative diseases
Castro‐Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 176
Skeletal muscle in amyotrophic lateral sclerosis
Shefner, J. M., Musarò, A., Ngo, S. T., Lunetta, C., Steyn, F. J., Robitaille, R., de Carvalho, M. A., Rutkove, S. B., Ludolph, A. C., & Dupuis, L. (2023) · Brain · doi:10.1093/brain/awad202 · Cited by 110
Metadata
- Authors
- Goutman, S. A., Hardiman, O., Al-Chalabi, A., Chió, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L.
- Affiliations
- University of Michigan (US)
- Trinity College Dublin (IE)
- University of Turin (IT)
- The University of Sydney (AU)
- Corresponding author
- Feldman, Eva L
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 21
- Issue
- 5
- Pages
- 480-493
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC9513753
- OpenAlex
- W4220676470
- Cited by
- 493
- References
- 107
- Citations by year
- 2026: 115 · 2025: 125 · 2024: 143 · 2023: 82 · 2022: 28
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Funders
- Seventh Framework Programme (259867)
- National Institute for Health Research Imperial Biomedical Research Centre
- Medical Research Council (MR/R024804/1, MR/L501529/1)
- Science Foundation Ireland (16/RC/3948, 13/RC2015)
- National Institute for Health Research (NIHR202421)
- National Institute of Neurological Disorders and Stroke (R01NS120926, R01NS127188)
- South London and Maudsley NHS Foundation Trust
- Ministero della Salute
- ALS Association
- National Institute of Environmental Health Sciences (R01ES030049, K23ES027221)
- Health Research Board
- National Health and Medical Research Council (APP1132524, APP1153439, APP1156093)
- University of Michigan
- Sinai Medical Staff Foundation
- Thierry Latran Foundation
- Horizon 2020
- Economic and Social Research Council (ES/L008238/1)
- Ministero dell’Istruzione, dell’Università e della Ricerca (2017SNW5MB)
- EU Joint Programme – Neurodegenerative Disease Research
- Motor Neurone Disease Association
- King's College London
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- amyotrophic lateral sclerosis, diagnosis, prognosis, survival models, disease staging, disease progression, fluid biomarkers, neuroimaging, phenotypes, end-of-life planning
- MeSH terms
- Amyotrophic Lateral Sclerosis, Electromyography, Humans, Prognosis, Biomarkers, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
